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6 Abstract
7 Rab geranylgeranyl transferase is an enzyme responsible for double geranylgeranylation of Rab proteins in all eukaryotic cells.
8 In the present article we would like to focus on new findings concerning the holoenzyme structure and mechanism of catalytic
9 activity, its mode of regulation and consequences of RGGT deficiency in different eucaryotic model organisms and patients.
10 Keywords: Rab geranylgeranyl transferase, Rab Escort Protein, choroideremia
11 Introduction
12 Protein prenylation is the post translational modifica-
13 tion leading to an attachment of a 15-carbon farnesyl or
14 20-carbon geranylgeranyl isoprenoid chain to a cyste-
15 ine residue in a protein by a tioether bond. Three
16 enzymes catalyse this modification: Farnesyl transfer-
17 ase (FT), Geranylgeranyl transferase I (GGT I) or Rab
18 geranylgeranyl transferase (RGGT syn. GGT II). The
19 cysteine is localized in a conserved amino acid motif at
20 the C-terminus of the polypeptide and the recognised
21 sequence is specific for each of the enzymes. FT and
22 GGT I recognize the -CAAX motif (cysteine, two
23 aliphatic amino acids, any amino acid) and RGGT
AQ424 recognizes the group of motifs -CXCX, -CCXX or
25 –XXCC. RGGT is an enzyme responsible exclusively
26 for prenylation of proteins belonging to the Rab
27 GTPase family. The RGGT complex is built of two
28 subunits: a and b forming a catalytic core and an
29 accessory, substrate presenting protein – Rab Escort
30 Protein (REP). The double geranylgeranylation
31 enables the proper localization of Rab proteins in the
32 cell membranes. Unmodified Rabs localize to the
33 cytoplasm where they are unable to perform their
34 normal function in vesicle budding, transport and
35 fusion.
36 The RGGT activity was discovered in 1980s and
37 since then has been the subject of increasing attention.
38 Many interesting aspects of the enzyme structure,
39 mode of substrate recognition and involvement in
40pathophysiology of human disease have been thor-
41oughly reviewed in earlier articles by Alory and Balch
42(2001), Leung et al. (2006), Hutagalung and Novick
43(2011), Nguyen et al. (2010) and Coussa and
44Traboulsi (2011).
45In the present article we would like to focus on new
46findings concerning the holoenzyme structure and
47mechanism of catalytic activity, its mode of regulation
48and consequences of RGGT deficiency in different
49eucaryotic model organisms and patients.
50The structure of RGGT
51Crystallographic studies on the structure of Rab
52Geranylgeranyl Transferase (RGGT) have started
53more than a decade ago with the release of the structure
54of the heterodimer of the a and b subunits of the rat
55enzyme (Zhang et al. 2000). So far, efforts to obtain the
56structure of the whole complex of RGGT ab hetero-
57dimer together with Rab Escort Protein (REP) bound
58to Rab protein and prenyl substrate (geranylgeranyl
59diphosphate GGPP) or prenylated product have not
60been successful due to the low diffraction of a crystal
61of such a multidomain complex (Rak et al. 2001,
62Wu et al. 2009). Structures of distinct functional
63modules of the complex (ab heterodimer of RGGT
64(Zhang et al. 2000), REP/monoprenylated Rab7
65(Rak et al. 2004), REP with ab heterodimer
66(Pylypenko et al. 2003) and structure of a ternary
67complex with truncated a subunit (Guo et al. 2008)
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68 have been solved experimentally leading to a detailed
69 computational model of the whole Rab geranylgera-
70 nylation machinery from mammals (Wu et al. 2009).
71 No structures of the enzymatic complex from other
72 organisms have been solved so far. Literature data on
73 the structure of the RGGT holoenzyme and the
74 catalytic mechanism of the RGGT enzymatic complex
75 are summarized in a following chapter.
76 a subunit of RGGT
77 The rat a subunit of RGGT (RGGTA) is very similar
78 to the corresponding a subunit of farnesylprotein
79 transferase (FT), containing 15 a-helices arranged in
80 a crescent-shaped, double layered right-handed super-
81 helix, enveloping the beta-subunit (Zhang et al. 2000).
82 Structurally it can be classified as a tetratricopeptide
83 repeat (TPR) superfamily protein. Phylogenetic anal-
84 ysis showed that the one and only duplication event of
85 CAAX prenyltransferase a subunit leading to RGGTA
86 subunit must have happened and the diversification
87 preceded the split of the eukaryotic main groups
88 (Rasteiro and Pereira-Leal 2007).
89 RGGTA subunit interacts with REP on one surface
90 andwithb subunit ofRGGT(RGGTB)on theopposite
91 surface of the protein (Pylypenko et al. 2003). The
92 contact side with REP covers a surprisingly small
93 area, compared with the large interaction surface of
94 both subunits of the ab heterodimer. Binding of REP
95 causes only small rearrangements in overall structure of
96 the RGGTAB heterodimer, mainly in the phosphoiso-
97 prenoid binding pocket in the RGGTB subunit and on
98 theREPbinding surface of theRGGTA.TheRGGTA/
99 REP interaction is allosterically regulatedby thebinding
100 of phosphoisoprenoid by the means of a long range
101 trans-domain transduction (Pylypenko et al. 2003).
102 Rat RGGTA displays a globular domain inserted in
103 the middle of the TPR domain. The function of this
104 insertion is unclear but it is not involved in contacts
105 either with REP or Rabs (Pylypenko et al. 2003) as
106 was suggested earlier (Zhang et al. 2000). This
107 domain belongs to a class of C2-like domains which
108 are involved in signalling, vesicular transport and
109 modification of lipids (Nalefski and Falke 1996).
110 C2s function in establishing phospholipid complexes;
111 sometimes they mediate protein-protein interactions
112 by direct binding to phosphotyrosine (Benes et al.
113 2005). This domain is not present in the yeast ortho-
114 logue and interestingly in a related a subunit of the
115 FT another domain, 310 helix, is inserted in the same
116 place. Only metazoa, plants and alveolata display
117 insertions of an IgG-like domain in this region of
118 RGGT. The domains in different groups of organisms
119 result from independent insertion or expansion
120 events. They are similar within taxonomical groups,
121but different beyond recognition across taxa (Rasteiro
122and Pereira-Leal 2007). Multiple insertions in the
123same site suggest that this site is capable of accom-
124modating structural variations more easily than
125others. Whether the structural diversity of this region
126between animals and plants is mirrored by the diver-
127sity of functions remains unknown.
128At the C-terminus of the rat RGGTA subunit a
129Leucine Rich Repeat domain is present, not found in
130the related FT. This domain is a right handed ba
131superhelix. LRRs are involved in the establishment of
132complexes with other proteins (Kobe and Kajava
1332001). LRR in RGGTA is not universal, it is found
134in some animals, angiosperms and alveolata. The
135phylogenetic data point to multiple losses of this insert
136during evolution (Rasteiro and Pereira-Leal 2007).
137RGGTA lacking the LRR and IgG domains is stable
138in a dimer with RGGTB subunit and shows prenyla-
139tion activity comparable to a wt enzyme (Guo et al.
1402008). The arrangement of the TPR domain of
141RGGTA subunit with the RGGTB subunit in the
142truncated enzyme is nearly identical to the structure of
143the intact complex.
144b subunit of RGGT
145The b subunit of RGGT (RGGTB) of rat is an a-a
146barrel composed of 12 a-helices, resembling the fold
147of the b subunit of farnesyltransferase (FT) and ger-
148anylgeranyltransferase I (GGT I) (Zhang et al. 2000).
149Generally, the b subunits are more conserved than the
150a ones. The isoprenoid (geranylgeranyl diphosphate
151[GGPP]) is held in the hydrophobic binding cleft
152buried in the barrel that is formed by the conserved
153aromatic residues. The phosphate moiety binds in a
154positively charged cleft that is located near the subunit
155interface and is close to the catalytic zinc ion. Binding
156of GGPP causes minor changes in the structure,
157mostly in the hydrophobic pocket. The region of
158binding of the phosphate group and carbons 1–12
159is very similar to GGT I but the bottom of the cavity is
160expanded, which makes RGGT more tolerant to the
161substitution of the distal part of the isoprenoid chain
162than other CAAX prenyltransferases (Nguyen et al.
1632009, 2010).
164Farnesyl diphosphate (FPP) functions as an efficient
165lipid donor for Rab prenylation in vitro, but farnesylated
166Rabshavenotbeen found invivo.This is likelydue to the
167fact that RGGT binds with 100-fold greater preference
168GGPPoverFPP,providinga thermodynamicallydriven
169selection of the appropriate lipid substrate. Crystalliza-
170tion of the enzyme with mono- and di-prenylated
171peptides showed that the lipidbindingcavity is occupied
172by the isoprenoid, but the electron density for the
173peptide part was very poor, indicatingweak interactions
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174 within the peptide-binding site. In contrast to the other
175 prenyltransferases, the RGGT does not possess the
176 exit groove for the product. This is also an indirect
177 indication that theaffinityof theprenylated intermediate
178 or product for RGGT is low.Mono- and di- prenylated
179 peptides bind with comparable low micromolar affini-
180 ties. The only strong interaction is by the lipid binding
181 site, and the second lipidation does not positively
182 contribute to the affinity of the interaction of the
183 enzyme and the product, di-geranylgeranylated Rab
184 (Guo et al. 2008).
185 Rab Escort Protein (REP)
186 The Rab Escort Protein (REP) belongs to the same
187 family as Rab GDP dissociation inhibitor (RabGDI)
188 (Waldherr et al. 1993, Ragnini et al. 1994). Its struc-
189 ture is composed of two subdomains. The crystal
190 structures of the REP protein in complex with the
191 mono-prenylated or C-terminally truncated Rab
192 revealed that Rab interacts with the Rab-binding plat-
193 form of REP via an extended interface involving
194 the switch 1 and 2 regions (Rak et al. 2004). The
195 C-terminus of the REP molecule acts as a mobile lid
196 covering a conserved hydrophobic patch on the surface
197 of REP that in the complex coordinates the
198 C-terminus of Rab proteins. Several functional motifs
199 such as the Rab-binding platform and the mobile
200 effector loop are highly conserved between REP and
201 RabGDI. The RGGT-binding site in domain II is
202 unique for REP. The C-terminal binding region
203 (CBR) binds the C-terminus of Rab and directs it
204 towards a lipid binding site located on domain II.
205 Mammalian REPs display an insertion between
206 domains I and II that is absent in RabGDIs. This
207 insert is not involved in contacts with the RGGT
208 subunits nor Rab substrates. Some phylogenetic
209 groups display a longer insert in this position of
210 REP protein, its sequence is not conserved; the inserts
211 are similar within taxa, but different across taxa
212 (Rasteiro and Pereira-Leal 2007). These inserts are
213 not similar to any other protein, in the crystal structure
214 of the rat enzyme they show no clear electron density
215 (Rak et al. 2004). By computer analysis the inserts are
216 predicted to have disordered structure, and probably
217 the regions are natively unfolded (Rasteiro and Pereira-
218 Leal 2007). They might have a regulatory function.
219 Similarly, the very C-terminus of REP is disordered in
220 the structure of REP and RGGT heterodimer in the
221 absence of Rab (Pylypenko et al. 2003). It appears that
222 the REP 36C-terminal amino acids form a lid covering
223 the CBR in the absence of Rab. In the structure of
224 Rab truncated of C-terminal tail, the two REP mole-
225 cules swap C-termini (Rak et al. 2004). In the structure
226 of REP-Rab complex the C-terminus of REP interacts
227with the C-terminus of Rab, albeit in an inverted
228direction of polypeptide chain (Rak et al. 2004).
229The hypervariable tail of Rab protein, consisting of
230amino acids C-terminal to the above mentioned motif
231interacting with REP and including prenylatable
232cysteines, do not substantially contribute to the affinity
233of Rab to REP (Wu et al. 2009). However, together the
234C-terminal hydrophobic motif (CIM) and the length of
235the spacer between it and prenylatable cysteines in Rab
236have a central function in Rab prenylation. Mutation in
237the CIM motif results in a 30-to 70-fold reduction in
238Rab-REP affinity. Deletion of the prenylation motif or
239even the whole 14 amino acids downstream of CIM
240has limited influence on the affinity of the interaction.
241Mutations in the CIM motif lead to underprenylation
242and mislocalization of Rabs in the cells (Rak et al.
2432004). Extension of the C-terminus by four or five
244arbitrarily chosen residues after the prenylatable
245cysteines does not decrease prenylation efficiency sug-
246gesting that substrate recognition is truly sequence
247independent (Guo et al. 2008). The C-terminus
248binding region (CBR) of REP appears to promote
249prenylation by enabling the localization of the Rab
250C-terminal cysteines in the vicinity of the RGGT active
251site. Binding of GDP-bound Rab to REP structuralizes
252the Rab Switch I and Switch II regions and strengthens
253the interaction, slowing the rate of GDP to GTP
254exchange. In the Rab GTP bound form, the structure
255of Switch II has a different conformation that would
256lead to a steric clash with REP.
257Out of 32 residues forming contacts on the REP-
258Rab interface only six are specific for REP and not
259GDI. Three of them are engaged in contacts with the
260C-terminus of Rab. The specific residues are located
261at the edges of the interaction interface (Rak et al.
2622004). REP protein may be mutagenized to perform
263both REP and GDI-like functions but not vice versa
264(Alory and Balch 2003).
265Prenylation of Rab proteins
266The following data led to a proposal of a model of Rab
267prenylation (Guo et al. 2008): The Rab GTPase
268domain is recognized by Rab-binding platform
269(RBP) of REP. Next the complex is tightened by the
270interaction of C-terminal hydrophobic motif on Rab
271(CIM) with the C-terminal Binding Region (CBR) on
272REP. This complex binds with high affinity to the
273RGGTA by an interaction of domain II of REP.
274The affinity is further strengthened by the interaction
275of the very C-terminus of Rab with the active site of
276RGGTB subunit. From this perspective one can view
277CIM as being analogous to the AAX motif of CAAX-
278type protein prenyltransferases working from a remote
279location.
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280 The lack of a well-defined substrate binding mode
281 also explains the variation in the observed sequence of
282 isoprenoid addition in the Rab geranylgeranylation
283 reaction. The order of prenylation of the two cysteines
284 is random, but themono-prenylated product of the first
285 reaction does not dissociate from the enzyme. The lack
286 of precise positioning and high affinity of the enzyme-
287 substrate interactionmaybe the causewhyRGGTis the
288 slowest prenyltransferase (K1 = 0.16/s, K2 = 0.04/s).
289 Following the secondprenylationfinally thehighaffinity
290 binding substrate GGPP dislodges the bulky product
291 from the active site. The di-prenylated Rab molecule
292 C-terminus consequently associates with the lipid-
293 binding site onREP.This induces REP conformational
294 change and liberates the RGGTAB heterodimer from
295 Rab-REP complex.
296 It is possible to predict the influence of a mutation in
297 a particular site of interaction on Rab affinity towards
298 REP (Rak et al. 2004, Guo et al. 2008,Wu et al. 2009).
299 However, so far it is still impossible to state arbitrarily
300 which Rab will have a higher affinity for REP in vitro,
301 since the binding surface is composed of many sepa-
302 rated interactions, as described above. An even more
303 complicated situation is encountered in vivo, where
304 both the affinity of particular Rabs towards REP and
305 the number of molecular species competing for the
306 interaction must be considered. Therefore the influ-
307 ence of REP (or RGGT) mutation on deficiency of
308 Rab proteins prenylation (all Rab species present in
309 particular cell/tissue) must be considered separately.
310 Some examples of cell or tissue specific influence of the
311 geranylgeranylation machinery are described in later
312 sections of this article.
313 Regulatory aspects of RGGT
314 Apart from the well documented function of the
315 RGGT complex machinery in Rab protein prenyla-
316 tion, some unexpected regulatory links of protein
317 transport to other cellular processes have been found.
318 The best documented results come from yeast genetic
319 interaction screens, however, the precise mechanism
320 of how the Rab geranylgeranylation activity may be
321 related to other cellular processes has not always been
322 proposed. Nevertheless, vesicular transport facilitated
323 by Rabs seem to be coupled to pre-mRNA splicing
324 and nutrient sensing (Fujimura et al. 1994, Jacoby
325 et al. 1998, Bialek-Wyrzykowska et al. 2000, Singh
326 and Tyers 2009) in yeast Saccharomyces cerevisiae as is
327 described in later sections. On the other hand, the
328 whole process of Rab geranylgeranylation in yeast is
329 strictly dependent on the GGPP substrate availability
330 (Miaczynska et al. 2001) and the genes responsible
331 for GGPP synthesis are often found in genetic
332 screens together with the RGGT complex (Newman
333and Ferro-Novick 1987, Vincent et al. 2003, Singh
334and Tyers 2009). The coupling of isoprenoid phos-
335phate level in a cell and Rab geranylgeranylation may
336be different in higher Eukaryotes.
337RGGT regulation by GGPP in yeast, mammals
338and plants
339Binding of the Rab-REP complex to mammalian
340RGGT was found to be strongly modulated by
341GGPP (Thoma et al. 2001a). The affinity of RGGT
342for the Rab-REP complex increases from 120–2 nM in
343the presence of GGPP. Affinity of doubly prenylated
344Rab-REP complex to RGGT was 2 and 18 nM in the
345absence and presence of the GGPP, respectively. Bind-
346ing of the new isoprenoid substrate molecule facilitates
347the diprenylated product release by RGGT. As was
348shown on the basis of crystal structures, RGGTA
349subunit changes conformation upon GGPP binding
350to RGGTB subunit by means of long distance alloste-
351ric interaction (Pylypenko et al. 2003). This confor-
352mational change in the RGGT-GGPP complex
353increases its affinity for REP and REP-Rab complex.
354GGPP plays three different roles in the catalytic cycle
355of the RGGT: as an allosteric activator, phosphoiso-
356prenoid donor and substrate release trigger (Thoma
357et al. 2001b). In yeast enzyme the Km values for the
358prenyl diphosphates are approximately an order of
359magnitude larger than for their mammalian counter-
360parts (Witter and Poulter 1996). This phenomenon
361may reflect differences in the concentrations of iso-
362prenoid metabolites in mammalian and fungal cells. In
363the case of yeast RGGT Km for GGPP is 40 nM and
364for prenylated Rab-REP or unprenylated Rab-REP
365both Km are 200 nM, GGPP does not influence the
366affinity of REP to RGGT, in contrast to the mamma-
367lian enzyme (Dursina et al. 2002), so it does not serve
368as an activator. Similarly to the mammalian enzyme the
369binding of a new molecule of lipid substrate enables
370product release. As it has been mentioned above, the
371synthesis and demand for GGPP as a substrate for
372geranylgeranylation of proteins in yeast are coupled.
373Despite differences in affinity of RGGT to GGPP,
374the mode of product release in mammalian RGGT
375resembles its yeast counterpart. In both cases there
376exists only one gene coding for the GGPP synthase.
377Moreover, human REP may substitute for its yeast
378counterpart in yeast mrs6-/- strain.
379In plants where several genes coding for GGPP
380synthases are present the situation might be strikingly
381different. Additionally, it should be taken into consi-
382deration that in plants isoprenoid precursors are
383derived from two biosynthetic pathways, unlike in yeast
384or mammals. The GGPP moieties used for geranyl-
385geranylation of proteins are synthesized mainly by a
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386 plastidial methylerythritol phosphate (MEP) pathway
387 (Gerber et al. 2009); however, the metabolite exchange
388 of the intermediates between the classical cytosolic
389 mevalonate (MVA) pathway and the plastidial MEP
390 pathway cannot be excluded (Skorupinska-Tudek
391 et al. 2008). Therefore, the availability of the meta-
392 bolites for geranylgeranylation must be completely
393 different than in yeast and animals. Interestingly, the
394 conserved amino acid residue involved in REP binding
395 to RGGTA subunit is changed in the whole plant
396 phylogenetic lineage. It is known that plant REP can-
397 not substitute for yeast REP in vivo due to this single
398 amino acid change. This situation may reflect a diffe-
399 rent mode of regulation of plant RGGT by isoprenoid
400 donor than in the case of mammalian and yeast
401 enzymes (Hala et al. 2005, Wojtas et al. 2007).
402 Genetic interactions of RGGT subunits in yeast
403 The first interesting, but not fully understood aspect
404 of RGGT genetic interactions is a suppressor role of
405 RGGT a and b subunits (together with other proteins
406 engaged in vesicle transport) in pre-mRNA splicing
407 (Vincent et al. 2003, Pandit et al. 2009).
408 Overexpression from bet4 gene (block in early
409 transport-coding for yeast RGGTA) suppresses the
410 mutation (butnot the complete loss) of clf1 spliceosome
411 assembly factor even though both proteins seem not to
412 interact with each other physically, since the affected
413 strain growth defect is rescued without detectable
414 improvement inpre-mRNAsplicing efficiency (Vincent
415 et al. 2003). The authors suggest that similarly to earlier
416 findings (Chen et al. 1998) mutations in splicing factor
417 genes cause the vesicular transport defect. Overexpres-
418 sion of genes responsible for the early stages (ER to
419 Golgi) of sorting may rescue the splicing phenotype
420 simply by increasing the pool of modified and active
421 transduction molecules if some of the molecules have
422 overlapping and redundant functions.Thismaybe true,
423 as a gene coding for ypt1p (yeast Rab), one of the main
424 ER to Golgi transport molecules, modified by RGGT
425 complex, is intronless. Interestingly, overexpression
426 of theRGGTBcodinggene,bet2, interferedwithgrowth
427 ofanother splicingdefective straincarrying themutation
428 in prp38 helicase (Pandit et al. 2009).
429 Another well documented genetic interaction of
430 RGGT complex subunit is mrs6 (yeast gene coding
431 for REP) suppression ofmrs2mutation (mrs2 is aMg2+
432 channel involved in mitochondrial cytochrome assem-
433 bly). mrs6p overproduction rescues the respiratory
434 deficiency in mrs2 strain (Waldherr et al. 1993); how-
435 ever, the precise mechanism has never been elucidated.
436 In parallel to the aforementioned mrs6 genetic inter-
437 action, the same gene (formerly calledmsi4) was disco-
438 vered as a multicopy suppressor of the ira1mutation in
439yeast (ira codes for a GTPase activating protein for
440ras2p, acting competitively with cdc25p guanine
441exchange factor for ras2, and upstream from adenylate
442cyclase in a pathway regulating response to the nutrient
443supply). mrs6 overexpression reverts the heat shock
444phenotype caused by accumulation of a high level of
445cAMP, stimulation of protein phosphorylation and
446lack of cell cycle arrest at G1 upon nutrient starvation
447in an ira1mutant strain (Fujimuraet al. 1994).Themrs6
448gene must therefore act negatively on the ras/cAMP
449pathway, downstream of the cAMP dependent protein
450kinase. The precise mechanism of this genetic interac-
451tion has never been solved, however, it has been more
452recently confirmed by the observation that mrs6 over-
453expression partially bypasses the growth defect caused
454byhyperactivationof thePKApathway in ras2Val19 strain
455(in which ras2p is constitutively active) (Singh and
456Tyers 2009).
457Themost interesting observations concerningmrs6p
458function have been published recently by two groups
459(Lempiainen et al. 2009, Singh and Tyers 2009). In
460two independent genetic screens in yeast the link
461between vesicular transport and TOR kinase signalling
462has been demonstrated. In search for a direct protein
463interaction, the sfp1 and mrs6p tight and stoichiomet-
464ric binding was discovered by the proteomic methods
465(Singh and Tyers 2009). The transcription factor
466sfp1 couples nutrient status to cell growth rate by
467controlling the expression of ribosome biogenesis
468(Ribi) and ribosomal protein (RP) genes. sfp1 is loca-
469lised to the nucleus in rich nutrients, but upon nutrient
470limitation or TOR pathway inhibition by rapamycin,
471sfp1 rapidly exits the nucleus, leading to repression of
472the Ribi and RP regulons. PKA signalling inhibition
473affects the localization status of sfp1. In a ras2Val19
474strain the nuclear localization of sfp1 is affected as
475well (Jorgensen et al. 2004).
476mrs6 protein exhibits a nutrient sensitive interaction
477with sfp1. Overexpresion of mrs6p prevents nuclear
478localization of sfp1 in rich nutrients and loss of mrs6p
479causes nuclear localization of sfp1 even in poor nutri-
480ents. Unexpectedly, this effect is independent of
481protein kinase C (Fujimura et al. 1994). mrs6p and
482sfp1 interaction links the secretory pathway and TOR
483dependent nutrient signalling to ribosome biogenesis.
484mrs6 is able to override the nutrient control of
485sfp1 localization. The TOR network and PKA network
486relay amino acid and glucose supply to the cellular
487machinery, but some of the targets of the kinases are
488different. So the regulation of sfp1 must be parallel to
489the PKA pathway.
490The authors also localized the probable site of inter-
491action of sfp1 and mrs6p. TOR, its activators and
492effectors localise to the internal membrane system.
493In a pull down-proteomic screen for interactors
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494 of sfp1 the prominent band was mrs6p. mrs6p was also
495 shown to localize in the ER/Golgi membranes
496 (Miaczynska et al. 1997). Its localization and sensitivity
497 to salt and detergents is very similar as for sfp1
498 and suggests that they may meet with TOR on the
499 endomembranes.
500 The interaction of sfp1 with mrs6p engage the same
501 surface on mrs6 protein that is occupied by Rabs. In a
502 screen for protein interactions, ypt1p overexpression
503 interfered with the growth of the mrs6/sfp1 strain. The
504 sec4p overexpression gave a weaker effect. Rapamycin-
505 resistant alleles ofmrs6, mimicking constitutively active
506 TOR, are defective for sfp1 relocalization. The muta-
507 tions in RGGT interactions, responsible for growth
508 defects and G2/M arrest (Bialek-Wyrzykowska et al.
509 2000) are separable from the mutations responsible for
510 sfp1 re-localization alleles. The location of the mrs6p
511 amino acid substitutions in the Rab-binding domain
512 suggests that the Rab and sfp1 compete for closely
513 juxtaposed binding sites on mrs6p.
514 In one of the non-lethalmrs6mutated strains,mrs6-2
515 (Bialek-Wyrzykowska et al. 2000), bi-nucleated cells
516 are formed. A similar effect is apparent in rho3 and
517 pkc1delta strains. General secretion defects do not
518 show the phenotype of nuclear segregation defects
519 that may be independent of the role of mrs6p in
520 geranylgeranylation. The slg supressor of mrs6-2 codes
521 for a protein able to activate pkc1p (Jacoby et al. 1998),
522 a kinase that mainly transmits the signals for transcrip-
523 tion of genes involved in cell wall biosynthesis and cell
524 cycle progression.
525 It remains unknown whether there is a link of the
526 machinery introducing geranylgeranyl groups to Rab
527 proteins (mrs6p/REP) and therefore having a role in
528 the intracellular transport, to one of the main regu-
529 latory proteins of cell growth in higher Eucaryotes
530 (TOR kinase). Moreover, a tempting possibility is
531 that the system is also regulated by the input from
532 other important regulatory kinase pathways, PKA
533 and PKC. In mammals a functional homologue
534 of TORC1 and mrs6p exist and the c-myc proto-
535 oncogene product has a similar function to sfp1.
536 c-myc is one of the few known regulators of RP
537 and Ribi genes, its function is linked to TOR and
538 PKA signalling, c-myc overexpression leads to
539 increased expression of genes encoding ribosomal
540 proteins (Lempiainen et al. 2009). The homologues
541 of ras, PKC and PKA are also present in mammals.
542 Plants, similarly to animals, lack the homologue of
543 sfp1 and its potential analogue, c-myc, but the
544 remaining elements of the machinery (TOR, PKA,
545 PKC, REP) are present. The potential similarities in
546 REP function as a molecular switch in nutrient
547 response in higher organisms cannot be ruled out;
548 this concept, however, needs experimental proof.
549RGGT complex regulation in higher
550Eukaryotes
551While compared to yeast, the knowledge on regula-
552tion of the RGGT complex in plants and animals still
553remains elusive. Some aspects of regulation and phe-
554notypic effects of RGGT or REP deficiency are
555described in the following section. Here attention
556will be paid to a few results directly concerning the
557aspects of RGGT regulatory roles.
558As a less obvious aspect of the RGGT complex
559activity we have to mention the results on the human
560protein phosphatase PRL2 function in the RGGT
561activity regulation (Si et al. 2001). Protein phospha-
562tase PRL2 was found to specifically interact with the
563RGGTB subunit in human HeLa cells and in yeast
564two-hybrid system. The protein is natively farnesy-
565lated (but never geranylgeranylated) and the modified
566form localizes to the early endosome while the
567unmodified one is found in the nucleus. The inter-
568action is strongly dependent on an intact farnesyl
569moiety and residues in the C-terminus preceding
570the CAAX motif, since an unmodified protein or
571one devoid of the C-terminus does not interact
572with RGGTB. Binding of RGGTA and PRL2 to
573RGGTB is mutually exclusive. By this means
574PRL2 overexpression inhibits RGGT activity. This
575suggests a cellular mechanism by which the activities
576of protein prenyltransferases may be reciprocally
577balanced.
578A very recent report (Lachance et al. 2011) states
579that the human RGGTA subunit interacts with a
580dileucine motif in the b2 adrenergic receptor to reg-
581ulate its maturation and trafficking. The receptor
582regulates Rab prenylation by RGGTA. The b2
583adrenergic receptor co-localizes with RGGTA to
584intracellular membrane compartments and the
585plasmamembrane. RGGTA binds the dileucine motif
586in the b2 adrenergic receptor C-terminus known to be
587involved in the transport of the receptor from the ER
588to the cell surface. RGGTA has a positive role in
589maturation and anterograde trafficking of the receptor
590and the receptor modulates the geranylgeranylation of
591some, but not all Rabs. The geranylgeranylation
592function in RGGTA and the receptor maturation
593competence are independent.
594Pathophysiological manifestations of RGGT
595activity impairment
596The following section attempts to summarize the
597consequences of RGGT impairment. Its structure
598reflects composition of the RGGT holoenzyme.
599Thus literature referring to the effects of the distur-
600bance in the cellular function of REP – the RGGT
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601 accessory protein – is followed by the observations
602 concerning heterodimeric enzyme subunits.
603 Rab Escort Protein
604 As mentioned earlier Rab Escort Protein is an acces-
605 sory subunit of RGGT absolutely required for proper
606 catalysis. So far at least one REP sequence has been
607 identified in all studied species. In contrast to most
608 species, mammals have two paralogous sequences –
609 REP1 (CHM) and REP2 (CHM-like, CHML),
610 sharing 75% amino acids identity (Cremers et al.
611 1994); duplication of REP has also been noted for
612 Xenopus laevis (Rasteiro and Pereira-Leal 2007).
613 Humans
614 REP1 is a CHM gene product and the CHM/REP1
615 gene is the only gene to date associated with chor-
616 oideremia (CHM), it refers to the absence of the
617 choroid. This rare inherited disease is caused by
618 loss-of-function mutations leading to a truncated,
619 non-functional, or rapidly degraded REP1 protein
620 (Scriver et al. 1995). CHM is an X-linked recessive
621 progressive retinal degeneration disease affecting
622 males and with milder symptoms in carrier females,
623 its incidence is 1 in 50,000. In CHM-affected males
624 night blindness is the most common first symptom in
625 childhood (first or second decade of life). As the
626 disease progresses constrictions of the visual field
627 and progressive loss of vision are noted. Most patients
628 are legally blind by their mid-40s (MacDonald et al.
629 1993). In parallel to the changes of visual acuity fine
630 pigmentary changes with focal choroidal atrophy
631 appear around the equatorial fundus (‘salt and
632 pepper’ pattern) and degeneration progresses more
633 centrally (atrophy of the choroid and retinal pigment
634 epithelium, RPE) (Coussa and Traboulsi 2011).
635 Female carriers of CHM are mostly asymptomatic,
636 except for the enlargement of the blind spot and
637 with clinical findings resembling those of young
638 affected males (patchy fundal pigmentation). This
639 characteristics could be explained by the hypothesis
640 of unbalanced X chromosome inactivation (the pres-
641 ence of embryologically distinct lines of photorecep-
642 tors and RPE clones expressing either the mutant or
643 normal REP1 allele) or by the X-autosomal translo-
644 cations of Xq21 (Coussa and Traboulsi 2011, and
645 references therein). Even though CHM is most often
646 an isolated ophthalmic disease a few reports of asso-
647 ciated abnormalities resulting from defects in the
648 REP1 adjacent loci have been reported (manifested
649 as psychomotor retardation, birth defects, deafness,
650 cognitive deficit) (Coussa and Traboulsi 2011, and
651 references therein).
652In humans CHM/REP1 loss-of-function mutations
653result most often in eye disease; lack of symptoms in
654other tissues is explained by the functional redun-
655dancy provided by the presence of REP2, CHML
656(choroideremia-like) gene product with 75% amino
657acid identity to REP1. REP-2 in mammals has
658emerged presumably through reversed transcription
659of REP-1 gene message and is devoid of introns that
660makes it refractory to mutations at splicing sites. Both
661REP1 and REP2 are ubiquitously expressed in human
662tissues (Cremers et al. 1994). Two possible explana-
663tions of CHM background have been suggested. The
664first hypothesis suggests that prenylation of different
665Rabs by REP1 and REP2 is performed with variable
666efficacy. Consequently, REP2 efficiently compensates
667for the loss of REP1 in all tissues except the eye where
668a subset of Rabs, such as Rab 27a remains under-
669prenylated (Seabra et al. 1995). According to the
670second hypothesis the rate of prenylation of Rab27a
671mediated by REP2 is only 2-fold lower than that
672mediated by REP1; however, the affinity of Rab27a
673is generally lower for both isoforms of REP. Compe-
674tition among all the cellular Rabs for REP2 upon
675reduction of overall REP activity caused by the
676absence of REP1 discriminates against those Rabs
677of low affinity (Rak et al. 2004). In contrast to
678REP1, no disease resulting from the loss of REP2
679has been identified so far.
680Several studies have been performed aimed at iden-
681tification of the molecular cause of the disease. Most of
682the pathogenic mutations reported so far in the human
683CHM gene result in a complete loss of REP1 protein or
684its function (MacDonald et al. 2004). A few selected
685reports are summarized below. In some CHM patients
686the CHM reading frame is maintained but the protein
687product lacks several amino acids belonging to the
688structurally conserved regions thus the disease is prob-
689ably caused by the loss of function of the REP-1 protein
690rather than by its absence (Garcia-Hoyos et al. 2008,
691Esposito et al. 2011). Analysis of the functional effects
692of some CHM mutations revealed a point mutation
693L550P which results in an unfolded protein product
694that is rapidly degraded. Analysis of the structure of this
695and three other mutated (shortened by 150 C-terminal
696amino acids or devoid of internal 473 or 100 amino
697acids) REP1 protein variants based on homology
698modeling (rat and human REP1 were superimposed)
699explained the effects of mutations as a loss of the
700REP1 essential activity or protein-protein interactions
701(Sergeev et al. 2009).
702To follow CHM pathogenesis and genotype/pheno-
703type correlations peripheral cells of CHM patients
704(primary skin fibroblasts and CD14+ fraction of
705monocytes) have been employed (Strunnikova et al.
7062009). pH was found to be increased in lysosomes of
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707 monocytes of CHM patients and consequently signi-
708 ficantly reduced rates of proteolytic abilities of the
709 monocytes were noted. Elucidation of the secretion
710 processes revealed significantly lower levels of secreted
711 cytokine/growth factors (macrophage chemoattractant
712 protein-1 MCP-1, pigment epithelial derived factor
713 PEDF, tumor necrosis factor TNFa, fibroblast growth
714 factor FGFb and interleukin IL-8) in CHM fibroblasts.
715 Microarray analysis revealed significant up-and-down
716 regulation of a number of genes involved in the
717 immune response, small GTPase regulation, secretion,
718 the regulation of transcription, cell adhesion and
719 the regulation of exocytosis in both CHM fibroblasts
720 and monocytes.
721 It has been also suggested that CHM could result
722 from genetically altered renewal systems (defect
723 of phagocytosis) in photoreceptors and the retinal
724 pigment (Rodrigues et al. 1984), however, the direct
725 connection with the dedicated Rab(s) remains elusive.
726 Rodents
727 Studies on rat tissues have revealed ubiquitous expres-
728 sion of both REPs (Seabra, 1996). Analysis of the
729 mRNA localization of Chm (coding for REP1) and
730 Chml (coding for REP2) transcripts in themouse retina
731 proved their overlapping broad expression profile,
732 however, the pattern of REP1 protein localization
733 was found to be different from what had been reported
734 in the human (Keiser et al. 2005).
735 Knock-out of the Chm gene results in much more
736 severe symptoms in animals.Mice with disruptedChm/
737 rep-1 gene were obtained by a gene targeting approach
738 which produced a mutated REP1 protein with a
739 C-terminal truncation of 274 amino acids (van den
740 Hurk et al. 1997). In these mice Chm KO is lethal in
741 hemizygous male embryos (Chm -/Y); in heterozygous
742 female embryos it is only lethal if the mutation is of
743 maternal (Chm-/Chm+) but not paternal (Chm+/Chm-)
744 origin (van den Hurk et al. 1997). HeterozygousChm+/
745 Chm- females are viable and exhibit progressive degen-
746 eration of the photoreceptors reminiscent of human
747 CHM. The observed imprinted pattern is explained
748 by the preferential inactivation of the paternally inher-
749 itedX-chromosome inmurine extra-embryonic tissues.
750 Abnormalities in extra-embryonic mouse tissues, yolk
751 sac and placenta (severe defects in vasculogenesis) have
752 been observed despite the presence of the Chml gene.
753 Moreover, it has been suggested that REP1 acts
754 in maintaining proliferation and in differentiation of
755 diploid trophoblast (Shi et al. 2004).
756 As mentioned above, heterozygous females are
757 unable to transmit the Chmnull allele to either hetero-
758 zygous females or hemizygous males. This problem
759 has been avoided by creating a conditional model
760of CHM – a tissue-specific (in the retinal pigment
761epithelium and photoreceptors, independently) and
762tamoxifen-inducible knockout of the Chm gene.
763Heterozygous females show early onset and progres-
764sive retinal degeneration similar to human CHM.
765Cell-autonomous degeneration associated with differ-
766ent subsets of underprenylated Rabs in photorecep-
767tors and retinal pigment epithelium has been observed
768(Tolmachova et al. 2006).
769Non-mammalian vertebrates
770In zebrafish and other non-mammalian vertebrates
771only a single chm gene encoding protein similar to
772mammalian REP is present. Mutation in the chm gene
773(a stop codon position at 32 out of 666 amino acids)
774results in a 90% reduction in inner ear hair-cell
775number, causing deafness, disequilibrium and abnor-
776mality of the lateral-line organ and partial retinal
777degeneration by 5 days post-fertilization (Starr et al.
7782004). Even though the loss of REP results in lethality
779of zebrafish larva, a transient rescue of the mutant is
780quite unexpected in light of the requirement for
781functional Rab-dependent vesicular transport
782machinery. This phenomenon has been attributed
783to the presence of the maternally derived chm tran-
784script in the larva (Starr et al. 2004). Careful exami-
785nation of the retinal phenotype of the rep mutant
786reveals consistency with CHM (photoreceptor dege-
787neration, loss of visual function, and defects in RPE
788pigmentation and outer segment phagocytosis)
789(Krock et al. 2007). Further studies of the same
790chm KO zebrafish (Moosajee et al. 2009) revealed
791catastrophic degeneration of the retina after 4.5 days-
792post-fertilization with a severe multisystem disease. At
793the late stage of these symptoms accumulation of
794unprenylated Rabs in the cytosol was demonstrated.
795It is suggested that the absence of full-length REP is a
796lethal mutation in zebrafish and that once the mater-
797nal supply derived from the egg sac is exhausted,
798RGGT dysfunction results in general cellular mal-
799function and death. Additionally, a pool of geranyl-
800geranylated Rabs of maternal origin might also persist
801for a time resulting in prolongation of the shortage of
802RGGT activity until the pool of prenylated Rabs had
803turned over (Moosajee et al. 2009).
804Invertebrates
805It has been suggested that in a model invertebrate
806Caenorhabditis elegans, the RGGT may function with-
807out REP activity, at least in some tissues (Tanaka et al.
8082008). rep-1 mutation is a single missense causing an
809amino acid substitution (E107K). This is probably a
810weak hypomorphic allele and not a null mutation.
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811 This mutant shows a mild defect in synaptic trans-
812 mission and in defecation behaviour. The disruption
813 of rep by siRNA showed mild, Rab27-dependent and
814 Rab3-independent defects in synaptic transmission at
815 neuromuscular junctions. The defects of rep-1 did not
816 cause such strong effects on defecation as defects in
817 the rab27 gene or rggta. However, the exact level of
818 REP inhibition in particular cells in the mutant strain
819 or the effectiveness of the siRNA treatment with anti-
820 rep siRNA was not specified. It is well known from
821 the yeast (Bialek-Wyrzykowska et al. 2000), plant
822 (Hala et al. 2005) and also mammalian (Detter
823 et al. 2000) models that even a low level of enzyme
824 activity sustains growth and basic functions of the
825 organism. Mutant animals (rep-1 and siRNA treated)
826 produce many lethal embryos but still are able to
827 reproduce in comparison to a complete sterility in
828 rggta siRNA-treated animals. Probably the defect is
829 correlated with abnormal germ-line development and
830 gonad morphology.
831 In all organisms studied so far REP has a broad
832 profile of expression but in Caenohabditis elegans the
833 authors suggest that it is not present in every cell.
834 In the rep-1 mutant the patterns of localization of
835 Rab5 and Rab7 have been disrupted partially and
836 in rep RNAi this effect was stronger, comparable to
837 rggta RNAi. The RNAi treatment has a smaller effect
838 on localization of Rab10 and Rab11. In Y2H
839 Rab5 and Rab7 showed interaction with REP and
840 Rab10 and Rab11 did not.
841 The authors suggest that some Rabs may require
842 REP for geranylgeranylation while some may be
843 modified by the RGGT heterodimer alone. Moreover
844 the requirement of REP for the same Rab may depend
845 on its site of action. In contrast to other organisms,
846 C. elegans RGGT would then possess a weak binding
847 affinity to some Rabs. Alternatively REP interacts
848 with all Rabs, but the binding affinity between REP
849 and each Rab may be easily affected by their envi-
850 ronment and correspond to the binding affinity of
851 Rab proteins with REP.
852 Yeast
853 In yeast mrs6/msi4, a homologue of REP1, is an essen-
854 tial gene (Fujimura et al. 1994). The conditional
855 mutant is impaired in protein transport to the vacuole
856 on the ER to Golgi step. In mutant cells a soluble
857 form of Ypt1p (Rab) accumulated, because level of
858 Ypt1p geranylgeranylation was very low. mrs6 overex-
859 pression caused a decrease in cell size on non-
860 fermentable carbon sources (Ragnini et al. 1994) but
861 depletion caused an increase in cell size in poor nutri-
862 ents (Singh and Tyers 2009). An opposite effect should
863 have been expected from a simple secretory system
864perturbation. Repression of mrs6 while grown on glu-
865cose (fermentable carbon source) compromised cell
866growth and caused a G2/M delay. Microscopic obser-
867vations of spores from a heterozygous mrs6 strain
868(completely lacking one copy of the gene) show 2:2
869segregation, the lethality was ascribed to the fact that
870spores either did not germinate or underwent not more
871than three cell divisions. A conditional mutant was
872lethal under non-permissive conditions, so the gene is
873important for both vegetative growth and germination
874(Ragnini et al. 1994). Overexpression of the mrs6
875protein can suppress the thermosensitive phenotype
876of the yptN121I/A161V mutant but not the absence of
877ypt1 protein (Ragnini et al. 1994). Mutational analysis
878of mrs6p led to the conclusions that mrs6p with
879deletions in the non-conserved C-terminal amino
880acid stretch or mutations in all but the first SCR
881were able to rescue the mrs6-/- conditional phenotype
882(Bauer et al. 1996). All the mutants sustaining growth
883were tested for geranylgeranylation activity and each
884showed a detectable (but sometimes lower than wt)
885activity. Mutated mrs6p and ypt1p showed to interact
886by the yeast two-hybrid assays and pull downs,
887albait with different strength. Interestingly, the
888C-terminal truncations of mrs6p lead to a protein
889with higher affinity to the ER and Golgi membranes
890(Miaczynska et al. 1997).
891Interesting studies, disclosing more information on
892mrs6p function and the effects of single amino acid
893changes in this important protein, are based on
894mutant mrs6-2 (Bialek-Wyrzykowska et al. 2000).
895This mutant, with reduced prenylation even at the
896permissive temperature, was constructed by random
897mutagenesis, causing a double mutation in a con-
898served region. Shift to a restrictive temperature causes
899no changes in growth of the mutant cells after 3 h, but
900reduces the amount of some Rab (sec4p) but not
901other (ypt1p) bound to membranes. For comparison,
902a complete lack of mrs6p prevents transport and
903causes the absence of Rabs on the membranes,
904as was mentioned earlier (Fujimura et al. 1994).
905Mutation mrs6-2 also causes defects in polarization
906and budding (cell division). The phenotype is attri-
907buted to dysfunction in polar transport along the
908cytoskeleton rather than vesicle budding or fusion,
909because there is no vacuole fragmentation or vesicle
910clusters near the bud, but only the even distribution of
911the vesicles in the cytoplasm (Bialek-Wyrzykowska
912et al. 2000). Genes involved in cell wall maintenance
913rescue the phenotype. mrs6-2 mutant does not
914show massive accumulation of ER, Golgi and PM
915as do mrs-/-, ypt-/- and sec4-/-, pointing to the fact
916that some Rabs remained functional, while others,
917underprenylated, could not perform their normal
918function.
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919 Elucidation of the pathogenic processes in choroideremia
920 It seems not clear whether CHM results from the
921 independent or sequential layer-by-layer degeneration
922 of retina, retinal pigment epithelium (RPE) and
923 choroid. There are three hypotheses based on the
924 clinical observations of CHM patients and on the
925 animal models mentioned above. (i) The suggestion
926 that RPE damage is a primary defect in CHM is based
927 on a study on the zebrafish model which indicates that
928 loss of REP1 from the RPE is sufficient for early
929 photoreceptor degeneration (Krock et al. 2007);
930 (ii) The concept of the independent photoreceptor
931 and RPE degeneration has been drawn from the results
932 of experiments with tissue specific CHM KO mice
933 (Tolmachova et al. 2006); and (iii) Photoreceptor
934 degeneration as the primary event has been based on
935 the studies of retinas of female mice chimeric for a
936 nonfunctional REP1 (van den Hurk et al. 1997). This
937 finding is consistent with the night blindness noted
938 early in CHMmale patients. So far the potential use of
939 gene augmentation therapy (Tolmachova et al. 2012)
940 and transplantation (Lund et al. 2001) have been
941 proposed as therapeutic alternatives.
942 a subunit of RGGT (RGGTA)
943 Analysis of the genome sequences revealed presence
944 of the rggta in all the eukaryotic species analyzed so
945 far (Rasteiro and Pereira-Leal 2007). Duplication of
946 the rggta has been noted exclusively for Arabidopsis
947 thaliana but not for other plants (Hala et al. 2010).
948 The best studied animal model indicating the
949 consequences of rggta mutation is gunmetal mouse
950 (gm mutation results from a G!A substitution in a
951 splice acceptor site) (Detter et al. 2000). RGGT acti-
952 vity and RGGTA protein levels were reduced 4-fold in
953 gm platelets. In line with this was the hypoprenylation
954 of the Rab27 protein. The residual RGGT activity is
955 ascribed to the aberrant splicing that to some extent
956 rescues RGGTA expression. The phenotype of the
957 homozygous gm mouse manifests as prolonged
958 bleeding caused by defects in platelets and megakar-
959 yocytes, macrothrombocytopenia and reduced platelet
960 a- and d-granule content (storage pool deficiency), the
961 megakaryocyte count is higher but they have abnormal
962 intracellular membranes, the animals also have partial
963 cutaneous albinism (Detter et al. 2000). The gm
964 phenotype resembles the rare human disorder gray
965 platelet syndrome (GPS) and platelet a,d-storage
966 pool deficiency. Moreover, association of RGGTA
967 with appropriate platelet function suggests applications
968 of RGGT inhibitors as a novel therapeutic strategy
969 for cure of thrombocytosis and clotting disorders, e.g.,
970 stroke (Detter et al. 2000).
971In a follow-up study (Li et al. 2000) analysis of the
9725¢-untranslated structure of the human RGGTA gene
973in patients with deficiencies of platelet-dense granules
974(a,d-storage pool deficiency) and GPS revealed
975similar exon/intron structural organization of the
9765¢-untranslated region of the human and gm mouse
977genes. However, exon alpha and intron alpha are not
978homologous between mouse and human. This analysis
979did not disclose any obvious disease-causing mutations
980of humanRGGTA, however, several polymorphisms of
981RGGTA including a putative cryptic splicing mutation
982in intron 4 were identified. Based on phenotypic
983similarities gunmetal mutant is sometimes considered
984as a model of the humanHermansky-Pudlak syndrome
985(symptoms include albinism, bleeding tendency and
986lung disease); however, definite arguments supporting
987this concept are still missing (Hutagalung and
988Novick 2011).
989Gunmetalmouse has also been used very recently to
990elucidate the effect of aberrant Rab prenylation on
991bone resorption (Taylor et al. 2011). gm osteoclasts
992exhibit a substantial reduction in resorptive activity
993in vitrowhile gm animals possessed slightly lower bone
994mass than controls, indicating also defects in osteo-
995blasts. Interestingly, gm mice were partially protected
996from ovariectomy-induced bone loss, suggesting that
997levels of Rab prenylation in gm osteoclasts may be
998sufficient to maintain normal physiological levels of
999activity, but not pathological levels of bone resorption
1000in vivo. In line with this bisphosphonates (inhibitors of
1001farnesyl diphosphate synthase, an enzyme providing
1002precursor for geranylgeranyl diphosphate synthesis)
1003together with inhibitors of RGGT have been used to
1004treat bone diseases characterized by extensive resorp-
1005tion, such as osteoporosis (Rogers et al. 2011, and
1006references therein). Moreover, RGGT inhibitors have
1007been shown to induce apoptosis in certain types of
1008cancer (Lawson et al. 2008) indicating the involve-
1009ment of geranylgeranylated Rab proteins in this
1010process.
1011Studies in yeast revealed that loss of RGGTA
1012activity is lethal in S. cerevisiae (Newman and Ferro-
1013Novick 1987).
1014b subunit of RGGT (RGGTB)
1015The presence of the RGGTB encoding genes has
1016been postulated in most of the analyzed eukaryotic
1017genomes. In some cases two (Tetraodon nigroviridis,
1018Ciona intestinalis, Monosiga brevicollis, Naegleria
1019gruberi) or even three (Danio rerio) RGGTBs have
1020been identified (Rasteiro and Pereira-Leal 2007).
1021Duplication of the b subunit, although also found
1022in many plants such as A. thaliana, Vitis vinifera,
1023Physcomitrella patens and Selaginella moellendorffii,
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1024 seems to be independent in each of the lineages and
1025 not a plant-specific feature.
1026 So far the effects of rggtb mutations have been
1027 characterized in A. thaliana. The sequence of
1028 AtRGGTB1 and B2 subunits are very similar to each
1029 other and to its mammalian homologue (Hala et al.
1030 2010). According to the data from Genevestigator, the
1031 rggtb1 transcript is abundant in all vegetative and
1032 generative tissues, rggtb2 transcript is less abundant
1033 than rggtb1 in vegetative, but expressed to a similar level
1034 to rggtb1 in generative male tissue.
1035 Disruption of Arabidopsis rggtb1 results in pleiotro-
1036 pic growth and developmental effects prominent in
1037 the shoot, but less visible in the root (Hala et al. 2010).
1038 The plants were dwarfed, showed loss of apical
1039 dominance and had abnormally developed flowers,
1040 however, both female and male generative organs
1041 remained fertile. The first symptoms of ageing are
1042 delayed in the mutant plants. Similarly to other trans-
1043 port machinery plant mutants, the rggtb1-/- shows a
1044 gravitropic defect of the shoot and does not etiolate in
1045 the dark. The biochemical data point to the deregu-
1046 lation of both exo- and endocytosis as well as to
1047 accumulation of unprenylated Rab proteins in the
1048 cytosol of the mutant plants. Ablation of the rggtb1
1049 gene product results in the reduction of Rab geranyl-
1050 geranylation activity to approx. 25% of the wt and the
1051 phenotypic changes affect the whole shoot and not
1052 only the specific organs or tissues as in mammalian
1053 mutants (gunmetal mice, CHM), suggesting a higher
1054 sensitivity of plants to defects of the secretion machin-
1055 ery. The authors speculate that deficient secretory
1056 pathway of the rggtb1-/- mutant can result in a defec-
1057 tive cell wall composition accompanied by a stress
1058 response (as was proposed for yeast geranylgeranyla-
1059 tion mutants (Newman and Ferro-Novick 1987,
1060 Bialek-Wyrzykowska et al. 2000) or a direct signalling
1061 feedback relay from the secretory pathway to the plant
1062 morphogenic program.
1063 Loss of RGGTB activity (bet2, block in early trans-
1064 port) is lethal in yeast. The bet2 mutant is thermo-
1065 sensitive for growth and accumulates ER membrane
1066 network even at a restrictive temperature making cells
1067 denser in transmission electron microscopy (Newman
1068 and Ferro-Novick 1987). This mutant has pleiotropic
1069 defects in many different steps of protein transport.
1070 Secretion of acid phosphatase to the periplasm and
1071 carboxypeptidase to the vacuole is inefficient and the
1072 accumulation of the immature ER form of invertase
1073 and alfa-mating factor precursors is evident.
1074 Rab GTPases
1075 Rabs, a diverse group of small GTPases, are master
1076 organizers of intracellular vesicular trafficking which
1077ensure transport specificity and designate organelle
1078identity. The role of disturbed vesicular trafficking
1079and aberrant Rab function in inherited and acquired
1080diseases has been summarized in an excellent review
1081(Mitra et al. 2011) published recently. Below men-
1082tioned are the disorders resulting exclusively from
1083the mutations in the rab genes resulting in defects
1084of Rab geranylgeranylation.
1085Mutations in Rab27A have been found in Griscelli
1086Syndrome Type 2 (GS2) patients characterized by
1087immunological defects, immunodeficiency and pig-
1088mentary dilution of the skin and hair. Rab27A plays
1089pivotal role in melanocytes as a member of a tripartite
1090machinery (Rab27A-myosin Va-melanophilin) respon-
1091sible for movement of melanosomes along the sublem-
1092mal actin network.Additionally, Rab27Aalso functions
1093in granule release within cytotoxic T lymphocytes.
1094Mutations in RAB27A account for most cases of GS
1095to date (van Gele et al. 2009). Most often these are
1096homozygous nonsense or frameshift mutations leading
1097to a premature stop codon and resulting in a truncated
1098proteindevoidofC-terminal geranylgeranylationmotif.
1099Similarly, truncation or missense mutations in
1100RAB23 have been identified as causative agents of
1101Carpenter syndrome which is a pleiotropic disorder
1102manifested by craniosynostosis, polysyndactyly,
1103obesity and cardiac defects; such symptoms are also
1104clinical characteristics of disorders associated with
1105impaired Sonic Hedgehog signaling. Interestingly,
1106Rab23 has been identified as a major negative regu-
1107lator of the Sonic Hedgehog pathway (Mitra et al.
11082011, and references therein).
1109The role of Rab in oncogenesis is broadly discussed
1110since aberrant endocytosis, vesicle targeting and
1111receptor recycling are involved in altering cell adhe-
1112sion, migration, proliferation, polarity, asymmetrical
1113division and overall survival. Indeed, aberrant expres-
1114sion of Rabs has been noted in various cancers. The
1115best characterized example is Rab25 which is a deter-
1116minant of tumor progression and aggressiveness of
1117some cancers (prostate, ovarian and breast cancer);
1118Rab25 does not play a role in tumor initiation but
1119rather facilitates its progression (Chia and Tang
11202009). Consequently Rabs might be considered
1121as future biomarkers for various cancers while
1122RGGT might serve as a target of anticancer therapy
1123(Hutagalung and Novick 2011).
1124Conclusions
1125In summary, the last few years have brought an
1126increasing interest in the function, mode of action
1127and regulation of the RGGT complex. Advanced
1128crystallographic studies have led to a mechanistic
1129model of action of mammalian RGGT in complex
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1130 with REP and Rab substrate. Sequence analysis of
1131 the subunits of the complex proved a high level of
1132 conservation and despite obvious biochemical dis-
1133 crepancies, the modes of action of the RGGT from
1134 mammals and other organisms seem not to differ
1135 very much.
1136 Much effort has been devoted to the construction
1137 of model organisms with knocked-out or down-
1138 regulated RGGT activity. The findings lead to the
1139 conclusion that the activity of this enzyme is indis-
1140 pensable for all eukaryotic organisms. The complete
1141 rggt or rep knock-outs in yeast, fish and mice are lethal.
1142 The mutant organisms with activity lowered either by
1143 mutation, siRNA treatment or silencing of one of two
1144 redundant genes revealed a general notion that even
1145 the low level of the RGGT activity is enough to sustain
1146 the basic functions in growth and development. The
1147 severity of the phenotype of the mutant is dependent
1148 on the particular level of function loss, with stronger
1149 manifestations in cells, tissues and processes strictly
1150 connected to vesicular transport.
1151 The studies on organisms with residual RGGT
1152 activity together with yeast genetics revealed unex-
1153 pected connections of RGGT subunits and processes
1154 of pre-mRNA splicing and nutrient sensing. The
1155 regulatory aspects of Rab geranylgeranylation and
1156 RGGT/REP additional cellular functions are promi-
1157 sing directions for future investigations.
1158 Manipulation of the activity level of RGGT by the
1159 use of specific inhibitors or gene therapy opens per-
1160 spective for new therapeutic strategies against inborn
1161 syndromes such as CHM or GPS as well as bone and
1162 blood clotting diseases and cancer.
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